Candriam Equities L Oncology Impact I/ LU1864482515 /
NAV30/10/2024 | Chg.-18.7800 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
2,215.1799GBP | -0.84% | reinvestment | Equity Worldwide | Candriam ▶ |
NAV30/10/2024 | Chg.-18.7800 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
2,215.1799GBP | -0.84% | reinvestment | Equity Worldwide | Candriam ▶ |